Summary
WASHINGTON - The Food and Drug Administration is likely to require antidepressants to carry strong, "black box" warnings about links between increased suicidal behavior in children who take the drugs, an agency official said Thursday.
A decision could come "within a few days," said Dr. Robert Temple, director of the Office of Medical Policy within the FDA's Center for Drug Evaluation and Policy.See the full content of this document
Extract
Antidepressant Warnings Expected
Testifying before a House subcommittee, Temple said patients also would receive information guides with every prescription on how to balance the risk of suicide wi...
See the full content of this document
Sponsored links
